Aptorum Group Limited - Class A Ordinary Shares (APM): Price and Financial Metrics

Aptorum Group Limited - Class A Ordinary Shares (APM): $2.17

0.29 (-11.79%)

POWR Rating

Component Grades








APM Price/Volume Stats

Current price $2.17 52-week high $13.00
Prev. close $2.46 52-week low $1.72
Day low $2.17 Volume 9,400
Day high $2.50 Avg. volume 168,600
50-day MA $2.13 Dividend yield N/A
200-day MA $3.30 Market Cap 7.75M

APM Stock Price Chart Interactive Chart >

APM Stock Summary

  • With a market capitalization of $8,176,969, APTORUM GROUP LTD has a greater market value than only 4.75% of US stocks.
  • With a one year PEG ratio of 0.33, APTORUM GROUP LTD is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 4.67% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, APTORUM GROUP LTD is reporting a growth rate of -251.73%; that's higher than merely 5.96% of US stocks.
  • If you're looking for stocks that are quantitatively similar to APTORUM GROUP LTD, a group of peers worth examining would be LGVN, FBIO, INFN, RYTM, and CYCN.
  • APM's SEC filings can be seen here. And to visit APTORUM GROUP LTD's official web site, go to www.aptorumgroup.com.

APM Valuation Summary

  • APM's price/sales ratio is 6.3; this is 57.5% higher than that of the median Healthcare stock.
  • Over the past 58 months, APM's EV/EBIT ratio has gone up 62.3.

Below are key valuation metrics over time for APM.

Stock Date P/S P/B P/E EV/EBIT
APM 2023-09-18 6.3 0.5 -0.8 -1.0
APM 2023-09-15 7.3 0.6 -1.0 -1.1
APM 2023-09-14 7.6 0.6 -1.0 -1.2
APM 2023-09-13 7.6 0.6 -1.0 -1.2
APM 2023-09-12 7.4 0.6 -1.0 -1.1
APM 2023-09-11 6.2 0.5 -0.8 -1.0

APM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • APM has a Quality Grade of C, ranking ahead of 44.63% of graded US stocks.
  • APM's asset turnover comes in at 0.027 -- ranking 360th of 680 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows APM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.027 -0.114 0.220
2019-12-31 0.016 -0.485 -0.814

APM Price Target

For more insight on analysts targets of APM, see our APM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $15.00 Average Broker Recommendation 1.5 (Moderate Buy)

Aptorum Group Limited - Class A Ordinary Shares (APM) Company Bio

Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.

APM Latest News Stream

Event/Time News Detail
Loading, please wait...

APM Latest Social Stream

Loading social stream, please wait...

View Full APM Social Stream

Latest APM News From Around the Web

Below are the latest news stories about APTORUM GROUP LTD that investors may wish to consider to help them evaluate APM as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning!

William White on InvestorPlace | August 28, 2023

Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets

NEW YORK, August 10, 2023--Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announced that it has received an approval letter from the Nasdaq Stock Market LLC ("Nasdaq") Listing Qualifications Department notifying the Company it is approved to transfer the listing of its Class A ordinary shares, from the Nasdaq Global Market to the Nasdaq Capital Market. On this basis, the previous two listing deficiencies regarding minimum stockhold

Yahoo | August 10, 2023

10 Oversold Global Stocks To Buy

In this piece, we will take a look at ten oversold global stocks to buy. If you want to skip our analysis of the global economic climate, then take a look at 5 Oversold Global Stocks To Buy. Like July, August is full of surprises on the data front. After the U.S. economy grew quite […]

Yahoo | August 5, 2023

Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma

NEW YORK & LONDON & PARIS, June 22, 2023--Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that the group has submitted the relevant Phase 1b/2a clinical trial protocol of SACT-1, an orally administered repurposed small molecule drug for the treatment of neuroblastoma to US FDA. The Phase 1b/2a study of SACT-1 submitted is for the combination with

Yahoo | June 22, 2023

Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris

NEW YORK & LONDON & PARIS, June 09, 2023--Regulatory News: Aptorum Group Limited (the "Company") (NASDAQ:APM, Euronext Paris:APM) announced today that following a comprehensive review of the trading volume, costs and administrative requirements related to its listing on Euronext Paris, it has decided to request the voluntary delisting of its shares (the "Aptorum Shares") (ISIN KYG6096M1226) from Euronext Paris. The Board of Euronext has approved this request.

Yahoo | June 9, 2023

Read More 'APM' Stories Here

APM Price Returns

1-mo -1.36%
3-mo -19.03%
6-mo -35.22%
1-year -81.45%
3-year -82.64%
5-year N/A
YTD -60.55%
2022 -63.33%
2021 -39.27%
2020 -84.42%
2019 4.41%
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!